Clinical Trial Update: A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027) [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and immune response of the RotaTeq rotavirus vaccine in elderly participants. The trial was terminated and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus | Phase 1 | Status: TERMINATED | Results posted: 2011-02-04